Aurobindo Pharma Eyes Rs 800 Cr Share Buyback

Aurobindo Pharma has announced a share buyback plan aiming to repurchase shares worth up to Rs 800 crore. The tender offer route has been chosen for this operation.

The buyback window is scheduled to open on April 23, 2026, and will close on April 29, 2026. The company intends to acquire shares at a price of Rs 1,475 per share. This offer covers a maximum of 54.23 lakh shares, constituting approximately 0.93% of the total outstanding equity.

Shareholders on record as of April 17, 2026, are eligible to participate. The buyback structure offers a higher acceptance ratio for small shareholders, with a specific allocation for reserved categories and another for the general category.

This move is seen as a modest reduction in share capital and a deployment of surplus cash. Management's confidence in the company's intrinsic value is often signaled by buybacks at a premium to market prices. The tender offer provides price certainty for shareholders wishing to tender their shares within the specified period.